Navigation Links
New report underlines the threat to universal access to HIV prevention, treatment and care due to a slow-down in treatment scale-up and waning political will

28 October 2010 (Geneva, Switzerland) - A report issued today by the International AIDS Society, Universal Access: Right Here, Right Now documents the principal debates around universal access during the XVIII International AIDS Conference (AIDS 2010). The report also takes stock of progress to date and reveals the scale of the future challenge for HIV treatment and prevention at a time when new infections are outstripping those receiving treatment by five to two.

While significant progress has been made towards achieving universal access to HIV prevention, treatment and care, with a consistent increase in funding for the AIDS sector between 2001 and 2008 resulting in an estimated 5.2 million people receiving life-saving treatment by 2009, compared with only 500,000 in 2003, the IAS report reveals that the progress made in the sector is under threat; the current economic challenges combined with a waning political will and a flat-lining of resources are preventing the international community from making universal access a reality.

AIDS 2010 took place in Vienna in July 2010 at a critical moment in the push for expanded access to HIV services. Coinciding with the original 2010 deadline set by world leaders for achieving universal access to HIV prevention, treatment and care, the conference was an important platform for ensuring that the universal access pledge remains on the global health agenda.

Dialogue on universal access during AIDS 2010 focused on two core issues: securing the required resources from international donors and national governments; and making more effective and efficient use of available resources. A key theme among speakers was the challenging economic climate, with principal donors including PEPFAR, the World Bank, UNITAID, and the Global Fund experiencing funding reductions or failing to increase funding in line with needs. The World Bank estimated that the cumulative effect of a diminished scale-up effort over five years would be approximately ten million deaths and 14 million newly infected individuals.

The replenishment of the Global Fund to Fight AIDS, TB and Malaria was of major concern to conference delegates, as political leaders and activists alike advocated for the full replenishment of the Fund in the October 2010 Replenishment Meeting. Recognised by the international community as an effective mechanism through which to disburse large amounts of resources rapidly, the replenishment of the Global Fund is vital to reaching both the health related MDGs and universal access by 2015. These concerns have since been proved right, with donors pledging only US $11.7 billion earlier this month - less than the lowest of the three financing scenarios envisaged by the Global Fund. This amount will feasibly only allow for the continuation of funding of existing programmes, with new programmes being funded at significantly lower levels than in recent years.

The question of whether or not the international AIDS community should concentrate on doing more with fewer resources, or whether it should continue to advocate for increased resources to fight HIV and AIDS was heavily debated at the conference, in particular in light of the new WHO treatment guidelines as well as recent advances in prevention and treatment technologies. While the push for greater efficiencies is imperative, there was unquestionable consensus that efficiencies alone cannot make up for the large gap in needed resources.

"UNAIDS used AIDS 2010 to launch the new Treatment 2.0 platform which emphasizes the prevention of new HIV infections in a way which is smarter, faster and better. Treatment 2.0 is rooted in the notion that HIV infections can be cut by up to one-third if there is a significant change in how ARVs are provided. This means increased coverage, which in turn means more resources," said IAS President Elly Katabira. "Improved efficiencies are essential, however the scale of current unmet need and the fact that an additional 30-50% of HIV-positive people are eligible to start ART immediately under new WHO treatment guidelines, means universal access cannot and will not be achieved without a substantial increase in resources for AIDS. At this critical juncture in the international AIDS response, we should not be talking about doing more with less, but doing more with more."

The report confirms that the HIV response has rapidly scaled up in recent years as a result not only of increased bilateral and multilateral funding, but also due to the reduction in the cost of treatment and the application of innovative methods of prevention. Key stakeholders in the HIV response have also adapted to the effective utilization of additional health-related platforms such as maternal and child health and family planning. The progress and results that have been achieved, while significant, remain below the targets for universal access. Programme scale-up based on demonstrated good practice, programme efficiency gains, and the continued call for increased resources to avert millions of infections worldwide, are essential to ensure that Universal Access to the prevention, care and treatment of HIV and AIDS will be a reality by 2015.


Contact: Lindsey Rodger
International AIDS Society

Related biology news :

1. Aware, Inc. Reports Third Quarter 2010 Financial Results
2. DGAC report offers food and nutrition practitioners insights on helping combat obesity epidemic
3. Harm reduction cigarettes can be more harmful than conventional brands, researchers report
4. TEEB report puts worlds natural assets on the global political radar
5. Japanese researchers report on liver transplantation studies using animal and iPS cells
6. Reportlinker Adds Global Biometrics Industry
7. Researchers report advances vs. preeclampsia, including potential prediction
8. Smithsonian reports regional sea temperature rise and coral bleaching event in Western Caribbean
9. Novocure reports data showing TTF therapy in combination with chemotherapy has the potential to increase overall survival for patients with advanced non-small cell lung cancer
10. IBIA Statement Regarding the Release of the National Research Council Report - Biometric Recognition: Challenges and Opportunities
11. In Parkinsons disease, brain cells abandon mitochondria, researchers report
Post Your Comments:
(Date:11/19/2015)... MOUNTAIN VIEW, Calif. , Nov. 19, 2015 /PRNewswire/ ... authentication market, Frost & Sullivan recognizes BIO-key with the ... Strategy Leadership. Each year, Frost & Sullivan presents this ... comprehensive product line catering to the needs of the ... which the product line meets and expands on customer ...
(Date:11/18/2015)... 2015 --> ... market report titled  Gesture Recognition Market - Global Industry ... 2021. According to the report, the global gesture recognition market was valued ... reach US$29.1 bn by 2021, at a CAGR of ... America dominated the global gesture recognition market ...
(Date:11/17/2015)... Nov. 17, 2015  Vigilant Solutions announces today that ... Board of Directors. --> ... retiring from the partnership at TPG Capital, one of ... over $140 Billion in revenue.  He founded and led ... the TPG companies, from 1997 to 2013.  In his ...
Breaking Biology News(10 mins):
(Date:11/30/2015)... Germany , November 30, 2015 ... Vienna, Austria to be held December ... (ECNR) in Vienna, Austria to ... wholly owned subsidiary of Vycor Medical, Inc. ("Vycor") (OTCQB: VYCO), ... NovaVision Therapy Suite at the 3rd European Congress of ...
(Date:11/27/2015)... , Nov. 27, 2015 /PRNewswire/--  Mallinckrodt plc (NYSE: ... today that it has closed the sale of its ... Guerbet (GBT- NYSE Euronext) in a transaction valued at ... manufacturing facilities and a total of approximately 1,000 employees ... St. Louis area. This entire ...
(Date:11/25/2015)... , November 26, 2015 ... Biobanking Market 2016 - 2020 report analyzes that ... integrity and quality in long-term samples, minimizing manual ... cost-effectiveness. Automation minimizes manual errors such as mislabeling ... efficiency. Further, it plays a vital role in ...
(Date:11/25/2015)... 25, 2015  Neurocrine Biosciences, Inc. (Nasdaq: NBIX ... and CEO of Neurocrine Biosciences, will be presenting at ... New York . .   ... approximately 5 minutes prior to the presentation to download ... presentation will be available on the website approximately one ...
Breaking Biology Technology: